171 related articles for article (PubMed ID: 26626889)
1. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
[TBL] [Abstract][Full Text] [Related]
2. In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
Xiao X; Sun J; Chen Y; Huang RJ; Huang T; Qiao GG; Zhou YF; Liu YH
BMC Vet Res; 2015 Feb; 11():33. PubMed ID: 25889187
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
Vilalta C; Giboin H; Schneider M; El Garch F; Fraile L
J Vet Pharmacol Ther; 2014 Dec; 37(6):542-9. PubMed ID: 24903473
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
[TBL] [Abstract][Full Text] [Related]
7. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
8. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
9. Effect of marbofloxacin on Haemophilus parasuis nasal carriage.
Vilalta C; Galofré N; Aragon V; Pérez de Rozas AM; Fraile L
Vet Microbiol; 2012 Sep; 159(1-2):123-9. PubMed ID: 22487455
[TBL] [Abstract][Full Text] [Related]
10. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
Zhao Y; Guo LL; Fang B; Liu B
PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs.
Yohannes S; Awji EG; Lee SJ; Park SC
Xenobiotica; 2015 Mar; 45(3):264-9. PubMed ID: 25470431
[TBL] [Abstract][Full Text] [Related]
13. PK/PD modelling of enrofloxacin against Glaesserella parasuis infection in pigs.
Yang B; Li XD; Chen X; Hong J; Liu C; Zheng JP; Ou ZY; Yu DJ
J Vet Pharmacol Ther; 2022 May; 45(3):291-300. PubMed ID: 35348230
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.
Mi K; Sun D; Li M; Hao H; Zhou K; Liu Z; Yuan Z; Huang L
Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498972
[No Abstract] [Full Text] [Related]
15. Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.
Lee SJ; Awji EG; Park NH; Park SC
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895011
[TBL] [Abstract][Full Text] [Related]
16. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.
Lorenzutti AM; Litterio NJ; Himelfarb MA; Zarazaga MDP; San Andrés MI; De Lucas JJ
J Vet Pharmacol Ther; 2017 Dec; 40(6):629-640. PubMed ID: 28470723
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S
Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
